deltatrials
Completed NA INTERVENTIONAL 1-arm NCT00686465

Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study (PETREC)

Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study. PET in Recurrent Cancer(PETREC)

Sponsor: Ontario Clinical Oncology Group (OCOG)

Conditions Breast Cancer Esophageal Cancer Head and Neck Cancer Lymphoma Non-small Cell Lung Cancer Ovarian Cancer
Interventions PET/CT scan
Updated 5 times since 2017 Last updated: Feb 15, 2013 Started: Mar 31, 2009 Primary completion: Nov 30, 2011 Completion: Jul 31, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00686465, this NA trial focuses on Breast Cancer and Esophageal Cancer and remains completed. Sponsored by Ontario Clinical Oncology Group (OCOG), it has been updated 5 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ontario Clinical Oncology Group (OCOG)
  • Ontario Ministry of Health and Long Term Care
Data source: Ontario Clinical Oncology Group (OCOG)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations